Mobilization of Hematopoietic Stem Cells for Use in Autologous Transplantation

Hollie Devine

D. Kathryn Tierney

Kim Schmit-Pokorny

Kathleen McDermott

CJON 2010, 14(2), 212-222. DOI: 10.1188/10.CJON.212-222
Autologous hematopoietic stem cell transplantation (HSCT) is a potentially curative therapeutic approach for various malignant hematologic and lymphoid diseases. Hematopoietic stem cells (HSCs) may be collected from the blood or the bone marrow. HSCs are capable of self-renewal and give rise to progenitor cells, multipotent cells that differentiate and proliferate into the mature cells of the blood and immune system. HSCs and progenitor cells are released from the bone marrow into the peripheral blood through a process called mobilization. HSCs then are collected from the blood in a process called apheresis and cryopreserved for administration following the high-dose preparative regimen. This article reviews stem cell biology, current mobilization strategies, use of novel mobilization agents, and nursing care of patients during the mobilization phase of autologous HSCT. Understanding the biology and process of HSC mobilization is critical for transplantation nurses to deliver and coordinate care during this complex phase of autologous HSCT.
Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.